.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer in 2014 for a massive $43 ...
.On the heels of a period 3 succeed that failed to excite entrepreneurs, Ironwood Pharmaceuticals is...
.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizi...
.Invite to recently's Chutes & Ladders, our roundup of considerable leadership hirings, shootings...
.Commemorating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer soun...
.AbbVie has actually returned to the source of its own antipsychotic goliath Vraylar looking for one...
.GenSight Biologics is actually weeks far from running out of funds. Again. The biotech just has eno...
.Monopar Rehabs is recuperating a drug coming from the scrap heap of AstraZeneca's rare health condi...
.Along with brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ...
.After developing a gene therapy alliance with Dyno Rehabs in 2020, Roche is actually back for addit...